CRT

PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, November 14, 2023
Well, Neck, Annual general meeting, DNA, Cervical cancer, Castration, ICI, PSA, ADC, Patient, Research, Lymph, E pluribus unum, Neoplasm, Cytokine, Cancer, Pembrolizumab, Oncology, Doctor of Philosophy, OS, Burtness, Webcast, Safety, Fourth grade, Food, Head, International, Radiation, PDS, Infection, Society, SOC, PDSB, KOL, Opinion, National Cancer Institute, IL12, Recurrence, CRT, CD8, Ferret, Nivolumab, Squamous-cell carcinoma, Biomarker, Standard works, HDAC, Clinical trial, NCI, FDA, Biotechnology, Vaccine, Prostate cancer, Immunotherapy, Survival, TH1, Prostate-specific antigen, Cetuximab, HPV, Docetaxel, Pharmaceutical industry, Medical imaging, Birth control, H1N1

The Company will provide a business update on its conference call and webcast at 8:00 AM EST today.

Key Points: 
  • The Company will provide a business update on its conference call and webcast at 8:00 AM EST today.
  • PDS Biotech anticipates initiation of VERSATILE-003 in Q1 2024.
  • PDS Biotech’s cash balance as of September 30, 2023 was approximately $54.3 million.
  • PDS Biotech believes that, with initiating the VERSATILE-003 Phase 3 clinical trial in the first quarter of 2024, its available cash resources will sustain operational and research and development endeavors into the third quarter of 2024.

KBRA Releases Research – 2024 RMBS Sector Outlook: Holding Steady With a Little Upside

Retrieved on: 
Monday, November 20, 2023
Finance, Other Construction & Property, Professional Services, Residential Building & Real Estate, Construction & Property, KBRA, CRT, LTV, Yoy, RMBS, FY, YTD

KBRA releases its 2024 RMBS Sector Outlook, which provides an update on key U.S. RMBS market and performance themes as of year-to-date (YTD) 2023, as well as issuance volume trends and forecasts for 2024, collateral performance trends, and rating surveillance outcomes.

Key Points: 
  • KBRA releases its 2024 RMBS Sector Outlook, which provides an update on key U.S. RMBS market and performance themes as of year-to-date (YTD) 2023, as well as issuance volume trends and forecasts for 2024, collateral performance trends, and rating surveillance outcomes.
  • In addition, we cover the RMBS 2.0 spread environment at pricing, plus other themes to watch in 2024.
  • RMBS 2.0 Spreads: The spread environment in 2023 YTD continued to exhibit volatility, with levels that were generally unfavorable across all sectors of RMBS.
  • Recent RMBS 2.0 Performance Trends: RMBS 2.0 YTD 2023 exhibited generally stable credit performance across all sectors.

Fannie Mae Announces 2024 Connecticut Avenue Securities (CAS) Issuance Calendar

Retrieved on: 
Wednesday, December 13, 2023
Transfer, Calendar, Fannie Mae, CAS, CRT, LTV, OTCQB, FNMA

WASHINGTON, Dec. 13, 2023 /PRNewswire/ -- Fannie Mae (OTCQB: FNMA) announced today its 2024 Connecticut Avenue Securities® (CAS) Issuance Calendar as part of its efforts to ensure transparency in the market.

Key Points: 
  • WASHINGTON, Dec. 13, 2023 /PRNewswire/ -- Fannie Mae (OTCQB: FNMA) announced today its 2024 Connecticut Avenue Securities® (CAS) Issuance Calendar as part of its efforts to ensure transparency in the market.
  • Fannie Mae has the option to issue, or forgo issuance of, one or more CAS deals during each window.
  • "Fannie Mae will be dynamic in its strategic approach to CRT issuance in 2024.
  • We currently expect total CAS volume of around $4 billion across 5-7 transactions, reflecting reduced single-family mortgage loan acquisitions in 2023," said Kathleen Pagliaro, Vice President of Credit Risk Transfer, Fannie Mae.

SXSW EDU® Announces Opening Keynote and Additional Featured Sessions for the 2024 Conference & Festival

Retrieved on: 
Wednesday, December 13, 2023
Civic, Congressional Black Caucus Foundation, Empowerment, Associate, Harlem Children's Zone, Policy, Innovation, AmeriCorps, Keynote, Conditional sentence, USA Today, History, Student, Research, CRT, Stanford University, SXSW, Critical race theory, African American Policy Forum, Mentorship, Poverty, Geoffrey Canada, Rutgers University, Teacher, Good, Education, Tutoring, Management, School

AUSTIN, Texas, Dec. 13, 2023 /PRNewswire/ -- SXSW EDU® is excited to continue building out the lineup for its upcoming conference and festival with the addition of an Opening Keynote on the debate over and misconceptions of Critical Race Theory (CRT). Featuring co-founder and executive director of The African American Policy Forum, Dr. Kimberlé Crenshaw, and vice president of the Center for Policy Analysis & Research at the Congressional Black Caucus Foundation, Dr. Jonathan Cox, the Keynote – presented as a fireside chat – invites attendees to explore the conceptual overview of CRT as well as the significance of integrating it into academia.

Key Points: 
  • AUSTIN, Texas, Dec. 13, 2023 /PRNewswire/ -- SXSW EDU® is excited to continue building out the lineup for its upcoming conference and festival with the addition of an Opening Keynote on the debate over and misconceptions of Critical Race Theory (CRT).
  • "SXSW EDU's mission has always been to offer discussions and perspectives on the matters impacting the state of education.
  • Because Critical Race Theory remains a significant topic in the field, it is fitting to open our 2024 conference and festival with a comprehensive discussion.
  • Additionally, SXSW EDU has unveiled a series of new Featured Sessions taking place during the convening from March 4-7, 2024.

Steel Partners Holdings Reports Third Quarter Financial Results and Declares Quarterly Distribution on its Series A Preferred Units

Retrieved on: 
Thursday, November 9, 2023
Other Professional Services, Asset Management, Professional Services, Finance, Tax, Financial services, Supply chain, CRT, Steel Connect, Repurchase agreement, Energy, EBITDA, Partnership, E series of preferred numbers, Capital expenditure, Associate company, Building material, Investment, Service provider, Financial services in Japan, ERP, Marketing, Retail, Cryptocurrency, Life insurance, Airline, Corporation

SG&A for the nine months ended September 30, 2023 increased $95,653, or 34.1%, as compared to the same period last year.

Key Points: 
  • SG&A for the nine months ended September 30, 2023 increased $95,653, or 34.1%, as compared to the same period last year.
  • The Company's effective tax rate was (1.4)% and 29.4% for the nine months ended September 30, 2023 and 2022, respectively.
  • The fluctuations for these periods were primarily due to the changes in fair value of the Company's investment in Steel Connect.
  • As of September 30, 2023, there were approximately 969,632 common units that may yet be purchased under the Repurchase Program.

Impulse Dynamics Receives Full-Body MRI-Conditional Approval for Optimizer Smart Mini System

Retrieved on: 
Monday, October 30, 2023
NYHA, FDA, MRI, Heart failure, Heart, CRT, Physician, Cardiac resynchronization therapy, Quality of life, CCM, HF, Mathematical optimization, Patient, Google Images, Medical imaging, Medical device

MARLTON, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today it has received whole-body MRI-conditional approval for the Optimizer® Smart Mini system from the United States Food and Drug Administration (FDA).

Key Points: 
  • MARLTON, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today it has received whole-body MRI-conditional approval for the Optimizer® Smart Mini system from the United States Food and Drug Administration (FDA).
  • The Optimizer Smart Mini system delivers the company’s proprietary CCM® therapy.
  • The approval for use with full-body MRI covers new patients adopting CCM therapy as well as existing Optimizer Smart Mini users.
  • Long‐term clinical experience with cardiac contractility modulation therapy delivered by the optimizer smart system.

Positive results from first-in-human completely leadless CRT in the US, published in The Journal of the American College of Cardiology

Retrieved on: 
Wednesday, October 25, 2023
NYHA, American College, Food, CRT, LVEF, Cardiac resynchronization therapy, Heel, McCutcheon, ASX, Achilles, Institutional review board, Coronary sinus, Wise, Journal, Cardiology, Patient, Food and Drug Administration, Heart failure, MD, Nissan Micra, JACC, Research, Growth, QRS, FDA, IRB, Cardiac electrophysiology, Journal of the American College of Cardiology, EBR, Medtronic, Failure, Medical device, Television, Pharmaceutical industry

The positive results published in JACC are based on a 1-year follow-up of the first-in-human implantation in the US of totally leadless CRT pacing utilizing the Micra™ leadless pacing system in the right ventricle in conjunction with EBR's investigational WiSE® CRT Electrode in the left ventricle of the heart.

Key Points: 
  • The positive results published in JACC are based on a 1-year follow-up of the first-in-human implantation in the US of totally leadless CRT pacing utilizing the Micra™ leadless pacing system in the right ventricle in conjunction with EBR's investigational WiSE® CRT Electrode in the left ventricle of the heart.
  • This first use in the US of the WiSE CRT System as a first-line therapy is a future market expansion opportunity for EBR.
  • "It's great to see these positive results being published in a world-leading cardiology journal, such as The Journal of the American College of Cardiology," said John McCutcheon, President & CEO of EBR Systems.
  • "This case study highlights the potential of totally leadless CRT for patients struggling with traditional CRT, but also beyond these patient groups, the 64 million heart failure patients across the globe."

Arch Capital Group Names Seamus Fearon CEO, International Mortgage

Retrieved on: 
Thursday, October 5, 2023
Banking, Professional Services, Insurance, Finance, Transfer, Mathematics, Faculty of Actuaries, Acquisition, CRT, Arch, Mathematical finance, Australian Prudential Regulation Authority, Dublin City University, Faculty, GSE, European Market Infrastructure Regulation, Capital Group Companies, Prudential regulation, Government-sponsored enterprise, Financial services

Arch Capital Group Ltd. (Arch) today announced Seamus Fearon has been promoted to CEO, International Mortgage for the Global Mortgage Group.

Key Points: 
  • Arch Capital Group Ltd. (Arch) today announced Seamus Fearon has been promoted to CEO, International Mortgage for the Global Mortgage Group.
  • In his new role, Fearon will be charged with further diversifying the platform of Arch’s Global Mortgage Group — the global leader in aggregating, managing and syndicating mortgage credit risk.
  • “Diversifying our mortgage portfolio has been a key strategy for the Global Mortgage Group over the last several years, and Seamus has played a critical role in growing our international business,” said David Gansberg, CEO of Arch’s Global Mortgage Group.
  • “Under Beau’s leadership, the International Mortgage group had many accomplishments including a first-of-its-kind capital relief transaction in Europe that helped establish our capabilities in that market.

Microtek Laboratories Introducing a Universal Conditioning, Year-Round, Controlled Room Temperature (CRT) Shipping Solution

Retrieved on: 
Tuesday, October 3, 2023
Microtek, CRT, Temperature, Family

DAYTON, Ohio, Oct. 3, 2023 /PRNewswire/ -- Temperature variation presents shipping problems for pharmaceuticals, medical devices, and other temperature-sensitive products. While this is most commonly associated with cold chain (2°C-8°C), it just as important to manage the temperature for controlled room temperature products (15°C-25°C). This type of temperature-controlled shipping can add extensive challenges including shipping costs, seasonal pack outs, and conditioning times. Today, Microtek Laboratories, Inc. (a CAVU Group company), is providing a solution.

Key Points: 
  • "With the ability to control temperature for a variety of industries, Microtek is a leader of thermal management solutions.
  • While continuing to advance our adaptek solutions, we are excited to be investing in the development of a total packaging solutions to further enhance temperature management and control."
  • Microtek Laboratories has expanded their offerings to validated shipping solutions that control temperature.
  • Microtek is a CAVU Group company – a privately held, family of companies, driven to provide manufacturers, suppliers and distributors with the industry's most advanced and complete temperature monitoring and management solutions.

PATRÓN® Tequila, Endorsed Additive Free by Tequila Regulatory Council (CRT)

Retrieved on: 
Monday, October 2, 2023
Pressure, Vanilla, Origin, Sugar, Innovation, Jarabe, Water, Agave, Ageing, CRT, Hand, Liquor

HAMILTON, Bermuda, Oct. 2, 2023  /PRNewswire/ -- PATRÓN® Tequila, the world's number one super-premium tequila,* is celebrating its (agave) roots by creating a new Additive Free seal that will be unveiled across the PATRÓN core portfolio, rolling out this fall. Honoring the brand's continued Additive Free endorsement from the Tequila Regulatory Council (CRT), this new seal will indicate to tequila drinkers that they can enjoy their PATRÓN with peace of mind, being fully confident that their tequila of choice is completely additive free. This endorsement bestowed by the tequila industry's governing body is a testament to how PATRÓN has remained committed to using only the highest quality, all natural ingredients — agave, water and yeast — at the core, since its inception. It's this mentality that's embedded within the time-honored PATRÓN production process that goes to extraordinary lengths to handcraft the finest tequila with no corrections or additives needed.

Key Points: 
  • The world's #1 super-premium tequila unveils a new Additive Free seal on packaging reinforcing the brand's time honored additive free process.
  • Honoring the brand's continued Additive Free endorsement from the Tequila Regulatory Council (CRT), this new seal will indicate to tequila drinkers that they can enjoy their PATRÓN with peace of mind, being fully confident that their tequila of choice is completely additive free.
  • While the demand for additive free products is surging, the increased popularity of tequila in recent years has put intense pressure on tequila makers to produce more tequila, faster.
  • To learn more about how PATRÓN has remained a steadfast leader of the additive free and super-premium categories, head to patrontequila.com .